Global High-Throughput Screening Services for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to High-Throughput Screening Services for Drug Discovery: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global High-Throughput Screening Services for Drug Discovery Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Chemical-based HTS Assays
1.2.3 Biological-based HTS Assays
1.2.4 Cell-based HTS Assays
1.2.5 Genetic-based HTS Assays
1.3 Market Segmentation by Application
1.3.1 Global High-Throughput Screening Services for Drug Discovery Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global High-Throughput Screening Services for Drug Discovery Revenue Estimates and Forecasts 2020-2031
2.2 Global High-Throughput Screening Services for Drug Discovery Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global High-Throughput Screening Services for Drug Discovery Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global High-Throughput Screening Services for Drug Discovery Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Chemical-based HTS Assays Market Size by Players
3.3.2 Biological-based HTS Assays Market Size by Players
3.3.3 Cell-based HTS Assays Market Size by Players
3.3.4 Genetic-based HTS Assays Market Size by Players
3.4 Global High-Throughput Screening Services for Drug Discovery Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global High-Throughput Screening Services for Drug Discovery Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global High-Throughput Screening Services for Drug Discovery Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America High-Throughput Screening Services for Drug Discovery Market Size by Type (2020-2031)
6.4 North America High-Throughput Screening Services for Drug Discovery Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America High-Throughput Screening Services for Drug Discovery Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe High-Throughput Screening Services for Drug Discovery Market Size by Type (2020-2031)
7.4 Europe High-Throughput Screening Services for Drug Discovery Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe High-Throughput Screening Services for Drug Discovery Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size by Type (2020-2031)
8.4 Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America High-Throughput Screening Services for Drug Discovery Market Size by Type (2020-2031)
9.4 Central and South America High-Throughput Screening Services for Drug Discovery Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America High-Throughput Screening Services for Drug Discovery Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa High-Throughput Screening Services for Drug Discovery Market Size by Type (2020-2031)
10.4 Middle East and Africa High-Throughput Screening Services for Drug Discovery Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa High-Throughput Screening Services for Drug Discovery Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Corporation Information
11.1.2 Eurofins Discovery Business Overview
11.1.3 Eurofins Discovery High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.1.4 Eurofins Discovery High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.1.5 Eurofins Discovery High-Throughput Screening Services for Drug Discovery Revenue by Product in 2024
11.1.6 Eurofins Discovery High-Throughput Screening Services for Drug Discovery Revenue by Application in 2024
11.1.7 Eurofins Discovery High-Throughput Screening Services for Drug Discovery Revenue by Geographic Area in 2024
11.1.8 Eurofins Discovery High-Throughput Screening Services for Drug Discovery SWOT Analysis
11.1.9 Eurofins Discovery Recent Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Corporation Information
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.2.4 Charles River Laboratories High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.2.5 Charles River Laboratories High-Throughput Screening Services for Drug Discovery Revenue by Product in 2024
11.2.6 Charles River Laboratories High-Throughput Screening Services for Drug Discovery Revenue by Application in 2024
11.2.7 Charles River Laboratories High-Throughput Screening Services for Drug Discovery Revenue by Geographic Area in 2024
11.2.8 Charles River Laboratories High-Throughput Screening Services for Drug Discovery SWOT Analysis
11.2.9 Charles River Laboratories Recent Developments
11.3 Axcelead
11.3.1 Axcelead Corporation Information
11.3.2 Axcelead Business Overview
11.3.3 Axcelead High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.3.4 Axcelead High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.3.5 Axcelead High-Throughput Screening Services for Drug Discovery Revenue by Product in 2024
11.3.6 Axcelead High-Throughput Screening Services for Drug Discovery Revenue by Application in 2024
11.3.7 Axcelead High-Throughput Screening Services for Drug Discovery Revenue by Geographic Area in 2024
11.3.8 Axcelead High-Throughput Screening Services for Drug Discovery SWOT Analysis
11.3.9 Axcelead Recent Developments
11.4 NUVISAN
11.4.1 NUVISAN Corporation Information
11.4.2 NUVISAN Business Overview
11.4.3 NUVISAN High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.4.4 NUVISAN High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.4.5 NUVISAN High-Throughput Screening Services for Drug Discovery Revenue by Product in 2024
11.4.6 NUVISAN High-Throughput Screening Services for Drug Discovery Revenue by Application in 2024
11.4.7 NUVISAN High-Throughput Screening Services for Drug Discovery Revenue by Geographic Area in 2024
11.4.8 NUVISAN High-Throughput Screening Services for Drug Discovery SWOT Analysis
11.4.9 NUVISAN Recent Developments
11.5 Axxam S.p.A.
11.5.1 Axxam S.p.A. Corporation Information
11.5.2 Axxam S.p.A. Business Overview
11.5.3 Axxam S.p.A. High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.5.4 Axxam S.p.A. High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.5.5 Axxam S.p.A. High-Throughput Screening Services for Drug Discovery Revenue by Product in 2024
11.5.6 Axxam S.p.A. High-Throughput Screening Services for Drug Discovery Revenue by Application in 2024
11.5.7 Axxam S.p.A. High-Throughput Screening Services for Drug Discovery Revenue by Geographic Area in 2024
11.5.8 Axxam S.p.A. High-Throughput Screening Services for Drug Discovery SWOT Analysis
11.5.9 Axxam S.p.A. Recent Developments
11.6 Evotec
11.6.1 Evotec Corporation Information
11.6.2 Evotec Business Overview
11.6.3 Evotec High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.6.4 Evotec High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.6.5 Evotec Recent Developments
11.7 Selvita
11.7.1 Selvita Corporation Information
11.7.2 Selvita Business Overview
11.7.3 Selvita High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.7.4 Selvita High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.7.5 Selvita Recent Developments
11.8 Azenta Life Sciences
11.8.1 Azenta Life Sciences Corporation Information
11.8.2 Azenta Life Sciences Business Overview
11.8.3 Azenta Life Sciences High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.8.4 Azenta Life Sciences High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.8.5 Azenta Life Sciences Recent Developments
11.9 Bienta (Enamine)
11.9.1 Bienta (Enamine) Corporation Information
11.9.2 Bienta (Enamine) Business Overview
11.9.3 Bienta (Enamine) High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.9.4 Bienta (Enamine) High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.9.5 Bienta (Enamine) Recent Developments
11.10 Cayman Chemical
11.10.1 Cayman Chemical Corporation Information
11.10.2 Cayman Chemical Business Overview
11.10.3 Cayman Chemical High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.10.4 Cayman Chemical High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Creative Biolabs
11.11.1 Creative Biolabs Corporation Information
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.11.4 Creative Biolabs High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.11.5 Creative Biolabs Recent Developments
11.12 Creative Bioarray
11.12.1 Creative Bioarray Corporation Information
11.12.2 Creative Bioarray Business Overview
11.12.3 Creative Bioarray High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.12.4 Creative Bioarray High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.12.5 Creative Bioarray Recent Developments
11.13 BOC Sciences
11.13.1 BOC Sciences Corporation Information
11.13.2 BOC Sciences Business Overview
11.13.3 BOC Sciences High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.13.4 BOC Sciences High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.13.5 BOC Sciences Recent Developments
11.14 MEDICILON
11.14.1 MEDICILON Corporation Information
11.14.2 MEDICILON Business Overview
11.14.3 MEDICILON High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.14.4 MEDICILON High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.14.5 MEDICILON Recent Developments
11.15 Domainex
11.15.1 Domainex Corporation Information
11.15.2 Domainex Business Overview
11.15.3 Domainex High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.15.4 Domainex High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.15.5 Domainex Recent Developments
11.16 Creative Diagnostics
11.16.1 Creative Diagnostics Corporation Information
11.16.2 Creative Diagnostics Business Overview
11.16.3 Creative Diagnostics High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.16.4 Creative Diagnostics High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.16.5 Creative Diagnostics Recent Developments
11.17 Multispan
11.17.1 Multispan Corporation Information
11.17.2 Multispan Business Overview
11.17.3 Multispan High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.17.4 Multispan High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.17.5 Multispan Recent Developments
11.18 AntalGenics
11.18.1 AntalGenics Corporation Information
11.18.2 AntalGenics Business Overview
11.18.3 AntalGenics High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.18.4 AntalGenics High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.18.5 AntalGenics Recent Developments
11.19 Creative Biostructure
11.19.1 Creative Biostructure Corporation Information
11.19.2 Creative Biostructure Business Overview
11.19.3 Creative Biostructure High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.19.4 Creative Biostructure High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.19.5 Creative Biostructure Recent Developments
11.20 BPS Bioscience
11.20.1 BPS Bioscience Corporation Information
11.20.2 BPS Bioscience Business Overview
11.20.3 BPS Bioscience High-Throughput Screening Services for Drug Discovery Product Features and Attributes
11.20.4 BPS Bioscience High-Throughput Screening Services for Drug Discovery Revenue and Gross Margin (2020-2025)
11.20.5 BPS Bioscience Recent Developments
12 High-Throughput Screening Services for Drug DiscoveryIndustry Chain Analysis
12.1 High-Throughput Screening Services for Drug Discovery Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 High-Throughput Screening Services for Drug Discovery Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global High-Throughput Screening Services for Drug Discovery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global High-Throughput Screening Services for Drug Discovery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global High-Throughput Screening Services for Drug Discovery Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global High-Throughput Screening Services for Drug Discovery Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global High-Throughput Screening Services for Drug Discovery Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global High-Throughput Screening Services for Drug Discovery by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High-Throughput Screening Services for Drug Discovery as of 2024)
Table 11. Global High-Throughput Screening Services for Drug Discovery Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global High-Throughput Screening Services for Drug Discovery Companies Headquarters
Table 13. Global High-Throughput Screening Services for Drug Discovery Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global High-Throughput Screening Services for Drug Discovery Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global High-Throughput Screening Services for Drug Discovery Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global High-Throughput Screening Services for Drug Discovery Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global High-Throughput Screening Services for Drug Discovery Revenue by Application (2026-2031) & (US$ Million)
Table 21. High-Throughput Screening Services for Drug Discovery High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America High-Throughput Screening Services for Drug Discovery Growth Accelerators and Market Barriers
Table 25. North America High-Throughput Screening Services for Drug Discovery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe High-Throughput Screening Services for Drug Discovery Growth Accelerators and Market Barriers
Table 27. Europe High-Throughput Screening Services for Drug Discovery Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific High-Throughput Screening Services for Drug Discovery Growth Accelerators and Market Barriers
Table 29. Asia-Pacific High-Throughput Screening Services for Drug Discovery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America High-Throughput Screening Services for Drug Discovery Investment Opportunities and Key Challenges
Table 31. Central and South America High-Throughput Screening Services for Drug Discovery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa High-Throughput Screening Services for Drug Discovery Investment Opportunities and Key Challenges
Table 33. Middle East and Africa High-Throughput Screening Services for Drug Discovery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Eurofins Discovery Corporation Information
Table 35. Eurofins Discovery Description and Major Businesses
Table 36. Eurofins Discovery Product Features and Attributes
Table 37. Eurofins Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Eurofins Discovery Revenue Proportion by Product in 2024
Table 39. Eurofins Discovery Revenue Proportion by Application in 2024
Table 40. Eurofins Discovery Revenue Proportion by Geographic Area in 2024
Table 41. Eurofins Discovery High-Throughput Screening Services for Drug Discovery SWOT Analysis
Table 42. Eurofins Discovery Recent Developments
Table 43. Charles River Laboratories Corporation Information
Table 44. Charles River Laboratories Description and Major Businesses
Table 45. Charles River Laboratories Product Features and Attributes
Table 46. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Charles River Laboratories Revenue Proportion by Product in 2024
Table 48. Charles River Laboratories Revenue Proportion by Application in 2024
Table 49. Charles River Laboratories Revenue Proportion by Geographic Area in 2024
Table 50. Charles River Laboratories High-Throughput Screening Services for Drug Discovery SWOT Analysis
Table 51. Charles River Laboratories Recent Developments
Table 52. Axcelead Corporation Information
Table 53. Axcelead Description and Major Businesses
Table 54. Axcelead Product Features and Attributes
Table 55. Axcelead Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Axcelead Revenue Proportion by Product in 2024
Table 57. Axcelead Revenue Proportion by Application in 2024
Table 58. Axcelead Revenue Proportion by Geographic Area in 2024
Table 59. Axcelead High-Throughput Screening Services for Drug Discovery SWOT Analysis
Table 60. Axcelead Recent Developments
Table 61. NUVISAN Corporation Information
Table 62. NUVISAN Description and Major Businesses
Table 63. NUVISAN Product Features and Attributes
Table 64. NUVISAN Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. NUVISAN Revenue Proportion by Product in 2024
Table 66. NUVISAN Revenue Proportion by Application in 2024
Table 67. NUVISAN Revenue Proportion by Geographic Area in 2024
Table 68. NUVISAN High-Throughput Screening Services for Drug Discovery SWOT Analysis
Table 69. NUVISAN Recent Developments
Table 70. Axxam S.p.A. Corporation Information
Table 71. Axxam S.p.A. Description and Major Businesses
Table 72. Axxam S.p.A. Product Features and Attributes
Table 73. Axxam S.p.A. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Axxam S.p.A. Revenue Proportion by Product in 2024
Table 75. Axxam S.p.A. Revenue Proportion by Application in 2024
Table 76. Axxam S.p.A. Revenue Proportion by Geographic Area in 2024
Table 77. Axxam S.p.A. High-Throughput Screening Services for Drug Discovery SWOT Analysis
Table 78. Axxam S.p.A. Recent Developments
Table 79. Evotec Corporation Information
Table 80. Evotec Description and Major Businesses
Table 81. Evotec Product Features and Attributes
Table 82. Evotec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Evotec Recent Developments
Table 84. Selvita Corporation Information
Table 85. Selvita Description and Major Businesses
Table 86. Selvita Product Features and Attributes
Table 87. Selvita Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Selvita Recent Developments
Table 89. Azenta Life Sciences Corporation Information
Table 90. Azenta Life Sciences Description and Major Businesses
Table 91. Azenta Life Sciences Product Features and Attributes
Table 92. Azenta Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Azenta Life Sciences Recent Developments
Table 94. Bienta (Enamine) Corporation Information
Table 95. Bienta (Enamine) Description and Major Businesses
Table 96. Bienta (Enamine) Product Features and Attributes
Table 97. Bienta (Enamine) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Bienta (Enamine) Recent Developments
Table 99. Cayman Chemical Corporation Information
Table 100. Cayman Chemical Description and Major Businesses
Table 101. Cayman Chemical Product Features and Attributes
Table 102. Cayman Chemical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Cayman Chemical Recent Developments
Table 104. Creative Biolabs Corporation Information
Table 105. Creative Biolabs Description and Major Businesses
Table 106. Creative Biolabs Product Features and Attributes
Table 107. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Creative Biolabs Recent Developments
Table 109. Creative Bioarray Corporation Information
Table 110. Creative Bioarray Description and Major Businesses
Table 111. Creative Bioarray Product Features and Attributes
Table 112. Creative Bioarray Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Creative Bioarray Recent Developments
Table 114. BOC Sciences Corporation Information
Table 115. BOC Sciences Description and Major Businesses
Table 116. BOC Sciences Product Features and Attributes
Table 117. BOC Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. BOC Sciences Recent Developments
Table 119. MEDICILON Corporation Information
Table 120. MEDICILON Description and Major Businesses
Table 121. MEDICILON Product Features and Attributes
Table 122. MEDICILON Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. MEDICILON Recent Developments
Table 124. Domainex Corporation Information
Table 125. Domainex Description and Major Businesses
Table 126. Domainex Product Features and Attributes
Table 127. Domainex Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Domainex Recent Developments
Table 129. Creative Diagnostics Corporation Information
Table 130. Creative Diagnostics Description and Major Businesses
Table 131. Creative Diagnostics Product Features and Attributes
Table 132. Creative Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Creative Diagnostics Recent Developments
Table 134. Multispan Corporation Information
Table 135. Multispan Description and Major Businesses
Table 136. Multispan Product Features and Attributes
Table 137. Multispan Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Multispan Recent Developments
Table 139. AntalGenics Corporation Information
Table 140. AntalGenics Description and Major Businesses
Table 141. AntalGenics Product Features and Attributes
Table 142. AntalGenics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. AntalGenics Recent Developments
Table 144. Creative Biostructure Corporation Information
Table 145. Creative Biostructure Description and Major Businesses
Table 146. Creative Biostructure Product Features and Attributes
Table 147. Creative Biostructure Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Creative Biostructure Recent Developments
Table 149. BPS Bioscience Corporation Information
Table 150. BPS Bioscience Description and Major Businesses
Table 151. BPS Bioscience Product Features and Attributes
Table 152. BPS Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. BPS Bioscience Recent Developments
Table 154. Raw Materials Key Suppliers
Table 155. Distributors List
Table 156. Market Trends and Market Evolution
Table 157. Market Drivers and Opportunities
Table 158. Market Challenges, Risks, and Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources


List of Figures
Figure 1. High-Throughput Screening Services for Drug Discovery Product Picture
Figure 2. Global High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Chemical-based HTS Assays Product Picture
Figure 4. Biological-based HTS Assays Product Picture
Figure 5. Cell-based HTS Assays Product Picture
Figure 6. Genetic-based HTS Assays Product Picture
Figure 7. Global High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Pharmaceutical Company
Figure 9. Biotechnology Company
Figure 10. High-Throughput Screening Services for Drug Discovery Report Years Considered
Figure 11. Global High-Throughput Screening Services for Drug Discovery Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 13. Global High-Throughput Screening Services for Drug Discovery Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Region (2020-2031)
Figure 15. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Chemical-based HTS Assays Revenue Market Share by Player in 2024
Figure 18. Biological-based HTS Assays Revenue Market Share by Player in 2024
Figure 19. Cell-based HTS Assays Revenue Market Share by Player in 2024
Figure 20. Genetic-based HTS Assays Revenue Market Share by Player in 2024
Figure 21. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Type (2020-2031)
Figure 22. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Application (2020-2031)
Figure 23. North America High-Throughput Screening Services for Drug Discovery Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) in 2024
Figure 25. North America High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) by Application (2020-2031)
Figure 27. US High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 28. Canada High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 30. Europe High-Throughput Screening Services for Drug Discovery Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) in 2024
Figure 32. Europe High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 35. France High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 37. Italy High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 38. Russia High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific High-Throughput Screening Services for Drug Discovery Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 44. Japan High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 46. Australia High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 47. India High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore High-Throughput Screening Services for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America High-Throughput Screening Services for Drug Discovery Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) in 2024
Figure 55. Central and South America High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil High-Throughput Screening Services for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina High-Throughput Screening Services for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa High-Throughput Screening Services for Drug Discovery Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) in 2024
Figure 61. South America High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa High-Throughput Screening Services for Drug Discovery Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries High-Throughput Screening Services for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 64. Israel High-Throughput Screening Services for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt High-Throughput Screening Services for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa High-Throughput Screening Services for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 67. High-Throughput Screening Services for Drug Discovery Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit